<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00502554</url>
  </required_header>
  <id_info>
    <org_study_id>4584</org_study_id>
    <nct_id>NCT00502554</nct_id>
  </id_info>
  <brief_title>Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation</brief_title>
  <official_title>Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mallinckrodt</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hannover Medical School</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of photopheresis as new therapy regimen in patients with bronchiolitis
      obliterans syndrome after lung transplantation in a controlled, randomized study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bronchiolitis obliterans syndrome is the major cause of mortality after lung transplantation.
      5 years after lung transplantation about 50% of all patients have this syndrome. There are
      nearly none therapy options. Besides effective therapy of any gastrooesophageal reflux and an
      oral medication with azithromycin none further regimens are known. Photopheresis could show
      in several studies a benefit for patients with gvhd after bone marrow transplantation or for
      chronic rejection after any other solid organ transplantation. Just little case reports could
      show beneficial effect in patients with bos after lung transplantation.

      This is the first controlled, randomized study with patients with bos after lung
      transplantation to investigate the effectiveness of this therapy in that patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    insufficient patient recruitment and ECP capacity
  </why_stopped>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FEV1 stabilisation</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Bronchiolitis Obliterans</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Observation with standard care (macrolides, exercise, oxygen therapy etc.) alone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2-day cycles of photopheresis every 3 weeks for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>photopheresis</intervention_name>
    <description>2-day cycles of photopheresis every 3 weeks for 3 months</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>photopheresis by Therakos</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Single/Double lung transplantation

          -  at least 6 months after lung transplantation

          -  bronchiolitis obliterans syndrome, Stadium &gt; 1 (nach ISHLT 2001, FEV1 &lt;80% Best), none
             other reason for worsening lung function (eg acute rejection, infection,
             extrapulmonary reasons, airway obstruction)

          -  none gastroesophageal reflux

          -  medication for &gt; 3 months with Azithromycin with further decrease of FEV1, MEF 25-75

          -  bioptic prove that there is no acute rejection

          -  no improvement under steroid pulse therapy

        Exclusion Criteria:

          -  tumor or hematologic disease

          -  acute rejection

          -  respiratory insufficiency (O2&gt;2l/min, pCO2 &gt;50 mm Hg)

          -  weight &lt; 40 kg

          -  acute infection

          -  colonization with multiresistant pathogens
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fuehner Thomas, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department Pneumology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department Pneumology, Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Dep. Pneumology</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2007</study_first_submitted>
  <study_first_submitted_qc>July 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2007</study_first_posted>
  <last_update_submitted>July 25, 2011</last_update_submitted>
  <last_update_submitted_qc>July 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2011</last_update_posted>
  <responsible_party>
    <name_title>Department for Respiratory Medicine</name_title>
    <organization>Hannover Medical School</organization>
  </responsible_party>
  <keyword>lung function</keyword>
  <keyword>FEV1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis Obliterans</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

